Valerie Michelle Oram, M.D.

NPI 1063654994ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· New York, NY

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in New York, New York, trained at New York University School of Medicine (class of 2004). Their prescriptions cost Medicare Part D more than their services did: $1,044,835 for 2,322 claims, against $37,683 paid for services in 2024. Lilly USA, LLC was the largest of 2 companies reporting payments in 2024, $89.90 in all, mostly food and beverage.

Overview

NPI	1063654994
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Mar 24, 2009
Last updated in NPPES	Mar 23, 2012

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Endocrinology, Diabetes & Metabolism Primary	207RE0101X	240824	NY

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Endocrinology (NY)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	250
Services billed	578 across 8 procedure codes
Paid by Medicare	$37,683

Part D prescriptions in 2024

Prescriptions (claims)	2,322 · 5,651 30-day fills
Patients	321
Total drug cost	$1,044,835
Generic share	54% of claims

Medicare sources and data years

Education and affiliations

Medical school	New York University School of Medicine
Graduation year	2004
Medicare specialty	Endocrinology
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth